Brief: Theraclion Ready To Launch 2nd Generation Of SONOVEIN
Oct 15 (Reuters) - THERACLION SA ALTHER.PA :
* THERACLION’S 2ND GENERATION BREAKTHROUGH TECHNOLOGY FOR
VARICOSE
VEIN TREATMENTS READY TO LAUNCH
* HAS OBTAINED CE MARK FOR THE SECOND GENERATION OF
SONOVEIN®,
IT’S HIFU TREATMENT SOLUTION FOR VARICOSE VEINS
* IT HAS ALSO SIGNED A STRATEGIC SUPPLIER PARTNERSHIP WITH
SUPERSONIC IMAGING (PART OF HOLOGIC INC.)
Source text for Eikon: ID:nBw9d2kvZa
Further company coverage: ALTHER.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))
Recent news on Theraclion SA
See all newsBrief: Theraclion Appoints Claude Lenoir As Interim Chairman
Brief: Theraclion Secures U.S. Reimbursement Milestone for Sonovein With New Category III CPT Code
French and Benelux stocks-Factors to watch
Brief: Inner Mongolia Furui Medical Raises Stake In Theraclion
Brief: French medical technology company Theraclion strikes partnership with Chinese company Furui and names new CEO